Literature DB >> 2035373

Twelve-lead electrocardiographic evaluation of ischemia during percutaneous transluminal coronary angioplasty and its correlation with acute reocclusion.

H S Bush1, J J Ferguson, P Angelini, J T Willerson.   

Abstract

The sensitivity of the surface 12-lead electrocardiogram and that of standard (limb-lead) monitoring for the detection of ischemia during percutaneous transluminal coronary angioplasty were compared in 115 patients. The purpose was to identify the electrocardiographic leads that provide the most sensitive indicators of coronary ischemia during percutaneous transaluminal coronary angioplasty and to evaluate the "ischemic fingerprint" that is obtained with 12-lead electrocardiogram during balloon inflation as a predictor of abrupt reocclusion after successful percutaneous transaluminal coronary angioplasty procedures. During balloon inflations of 30 seconds, ischemia was detected in 61 of 145 vessels (42%) by limb-lead monitoring alone versus 130 of 145 vessels (90%) by 12-lead electrocardiography (p less than or equal to 0.001). In the nine patients (7.8%) who experienced abrupt reocclusion within 24 hours, the electrocardiogram during chest pain after percutaneous transaluminal coronary angioplasty was identical to that obtained during percutaneous transaluminal coronary angioplasty ("ischemic fingerprint"). None of the six patients who had chest pain after percutaneous transaluminal coronary angioplasty without evidence of abrupt reocclusion reproduced their ischemic fingerprint. The suggested optimal leads for monitoring ischemia are as follows: left anterior descending coronary artery, V2, and V3; circumflex artery, V2, and V3; and right coronary artery, III and aVF.

Entities:  

Mesh:

Year:  1991        PMID: 2035373     DOI: 10.1016/0002-8703(91)90001-x

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  4 in total

Review 1.  Chest pain after coronary interventional procedures. Incidence and pathophysiology.

Authors:  A Jeremias; S Kutscher; M Haude; D Heinen; D Baumgart; J Herrmann; R Erbel
Journal:  Herz       Date:  1999-04       Impact factor: 1.443

2.  High-risk coronary angioplasty assisted by active hemoperfusion. A feasibility study.

Authors:  P Angelini; C Hernandez; J J Ferguson; R D Leachman; J A Garcia-Gregory; J Benrey; M J Schnee; S F Fighali; Z Krajcer
Journal:  Tex Heart Inst J       Date:  1996

3.  Absence of beneficial effect of intravenous metoprolol given during angioplasty in patients with single-vessel coronary artery disease.

Authors:  J W de Jong; J J Bonnier; T Huizer; R Ciampricotti; J R Roelandt
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

4.  EKG Criteria for Fibrinolysis: What's Up with the J Point?

Authors:  Joseph Brownfield; Mel Herbert
Journal:  West J Emerg Med       Date:  2008-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.